跳到正文
原文
Endpoints News 生物医药· Max Bayer·· 10 天前AI 评分50

FDA 要求 GLP-1 药企更新说明书,提醒罕见眼病风险

FDA orders GLP-1 drugmakers to warn of rare eye disease

AI 导读

FDA 要求 GLP-1 药企更新说明书,提醒罕见眼病风险,可能影响同类产品的监管要求。

正文

The FDA told GLP-1 drug­mak­ers to up­date their prod­uct la­bels to re­flect an in­creased risk of a rare eye con­di­tion that could lead to blind­ness.

…

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news